# Ducommun Inc: financial statements, quarterly

DCO · NYSE · CIK 30305 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dco.md) · [Financials](/companies/dco/financials.md) · [Filings](/companies/dco/filings.md) · [Insiders](/companies/dco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [196](/filings/0001628280-24-045949.md) | [192 d](/filings/0001628280-26-032536.md) | [192](/filings/0001628280-26-032536.md) | [196](/filings/0001628280-26-032536.md) | [201](/filings/0001628280-26-032536.md) | [197](/filings/0001628280-26-032536.md) | [192](/filings/0001628280-26-033836.md) | [201](/filings/0001628280-26-053776.md) | [214](/filings/0001628280-26-032536.md) | [217](/filings/0001628280-26-032536.md) | [209](/filings/0001628280-26-033836.md) | [224](/filings/0001628280-26-053776.md) |
| Cost of revenue | $m | [152](/filings/0001628280-24-045949.md) | [151 d](/filings/0001628280-26-032536.md) | [145](/filings/0001628280-26-032536.md) | [145](/filings/0001628280-26-032536.md) | [149](/filings/0001628280-26-032536.md) | [151](/filings/0001628280-26-032536.md) | [142](/filings/0001628280-26-033836.md) | [148](/filings/0001628280-26-053776.md) | [155](/filings/0001628280-26-032536.md) | [158](/filings/0001628280-26-032536.md) | [153](/filings/0001628280-26-033836.md) | [162](/filings/0001628280-26-053776.md) |
| Gross profit | $m | [44.6](/filings/0001628280-24-045949.md) | [41.7 d](/filings/0001628280-26-032536.md) | [47.1](/filings/0001628280-26-032536.md) | [51.1](/filings/0001628280-26-032536.md) | [52.7](/filings/0001628280-26-032536.md) | [46.4](/filings/0001628280-26-032536.md) | [50.5](/filings/0001628280-26-033836.md) | [53.0](/filings/0001628280-26-053776.md) | [59.0](/filings/0001628280-26-032536.md) | [59.2](/filings/0001628280-26-032536.md) | [56.2](/filings/0001628280-26-033836.md) | [62.9](/filings/0001628280-26-053776.md) |
| Selling, general and administrative | $m | [32.2](/filings/0001628280-24-045949.md) | [31.0 d](/filings/0001628280-26-032536.md) | [33.1](/filings/0001628280-26-032536.md) | [46.6](/filings/0001628280-26-032536.md) | [35.3](/filings/0001628280-26-032536.md) | [33.6](/filings/0001628280-26-032536.md) | [45.1](/filings/0001628280-26-033836.md) | [34.6](/filings/0001628280-26-053776.md) | [34.0](/filings/0001628280-26-032536.md) | [34.1](/filings/0001628280-26-032536.md) | [40.5](/filings/0001628280-26-033836.md) | [34.6](/filings/0001628280-26-053776.md) |
| Operating income | $m | [8.6](/filings/0001628280-24-045949.md) | [8.9 d](/filings/0001628280-26-032536.md) | [12.6](/filings/0001628280-26-032536.md) | [3.3](/filings/0001628280-26-032536.md) | [15.4](/filings/0001628280-26-032536.md) | [10.9](/filings/0001628280-26-032536.md) | [5.0](/filings/0001628280-26-033836.md) | [17.7](/filings/0001628280-26-053776.md) | [(75.3)](/filings/0001628280-26-032536.md) | [16.9](/filings/0001628280-26-032536.md) | [15.7](/filings/0001628280-26-033836.md) | [28.3](/filings/0001628280-26-053776.md) |
| Income tax | $m | [0.0](/filings/0001628280-24-045949.md) | [(1.3) d](/filings/0001628280-26-032536.md) | [2.4](/filings/0001628280-26-032536.md) | [(0.0)](/filings/0001628280-26-032536.md) | [2.2](/filings/0001628280-26-032536.md) | [0.7](/filings/0001628280-26-032536.md) | [0.3](/filings/0001628280-26-033836.md) | [3.7](/filings/0001628280-26-053776.md) | [(17.4)](/filings/0001628280-26-032536.md) | [3.5](/filings/0001628280-26-032536.md) | [1.8](/filings/0001628280-26-033836.md) | [4.4](/filings/0001628280-26-053776.md) |
| Net income | $m | [3.2](/filings/0001628280-24-045949.md) | [5.1 d](/filings/0001628280-26-032536.md) | [6.4](/filings/0001628280-26-032536.md) | [(0.7)](/filings/0001628280-26-032536.md) | [9.4](/filings/0001628280-26-032536.md) | [6.6](/filings/0001628280-26-032536.md) | [1.4](/filings/0001628280-26-053776.md) | [12.8](/filings/0001628280-26-053776.md) | [(60.8)](/filings/0001628280-26-032536.md) | [9.3](/filings/0001628280-26-032536.md) | [9.9](/filings/0001628280-26-053776.md) | [20.4](/filings/0001628280-26-053776.md) |
| Diluted EPS | $ per share | [0.22](/filings/0001628280-24-045949.md) | not reported | [0.43](/filings/0001628280-26-032536.md) | [(0.05)](/filings/0001628280-26-032536.md) | [0.63](/filings/0001628280-26-032536.md) | [0.44](/filings/0001628280-26-032536.md) | [0.09](/filings/0001628280-26-033836.md) | [0.84](/filings/0001628280-26-053776.md) | [(4.06)](/filings/0001628280-26-032536.md) | [0.60](/filings/0001628280-26-032536.md) | [0.64](/filings/0001628280-26-033836.md) | [1.31](/filings/0001628280-26-053776.md) |
| Basic EPS | $ per share | [0.22](/filings/0001628280-24-045949.md) | not reported | [0.43](/filings/0001628280-26-032536.md) | [(0.05)](/filings/0001628280-26-032536.md) | [0.64](/filings/0001628280-26-032536.md) | [0.44](/filings/0001628280-26-032536.md) | [0.09](/filings/0001628280-26-033836.md) | [0.85](/filings/0001628280-26-053776.md) | [(4.06)](/filings/0001628280-26-032536.md) | [0.62](/filings/0001628280-26-032536.md) | [0.66](/filings/0001628280-26-033836.md) | [1.35](/filings/0001628280-26-053776.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [27.2](/filings/0001628280-23-037539.md) | [42.9](/filings/0001628280-25-008401.md) | [32.1](/filings/0001628280-26-032536.md) | [29.4](/filings/0001628280-26-032536.md) | [37.3](/filings/0001628280-26-032536.md) | [37.1](/filings/0001628280-26-032536.md) | [30.7](/filings/0001628280-26-033836.md) | [37.1](/filings/0001628280-26-053776.md) | [50.9](/filings/0001628280-26-032536.md) | [45.3](/filings/0001628280-26-053776.md) | [39.1](/filings/0001628280-26-033836.md) | [39.8](/filings/0001628280-26-053776.md) |
| Current assets | $m | [557](/filings/0001628280-23-037539.md) | [550](/filings/0001628280-25-008401.md) | [563](/filings/0001628280-26-032536.md) | [569](/filings/0001628280-26-032536.md) | [570](/filings/0001628280-26-032536.md) | [568](/filings/0001628280-26-032536.md) | [578](/filings/0001628280-26-033836.md) | [596](/filings/0001628280-26-053776.md) | [682](/filings/0001628280-26-032536.md) | [626](/filings/0001628280-26-053776.md) | [634](/filings/0001628280-26-033836.md) | [661](/filings/0001628280-26-053776.md) |
| Total assets | $m | [1,142](/filings/0001628280-23-037539.md) | [1,121](/filings/0001628280-25-008401.md) | [1,131](/filings/0001628280-26-032536.md) | [1,132](/filings/0001628280-26-032536.md) | [1,130](/filings/0001628280-26-032536.md) | [1,126](/filings/0001628280-26-032536.md) | [1,128](/filings/0001628280-26-033836.md) | [1,139](/filings/0001628280-26-053776.md) | [1,250](/filings/0001628280-26-032536.md) | [1,186](/filings/0001628280-26-053776.md) | [1,185](/filings/0001628280-26-033836.md) | [1,225](/filings/0001628280-26-053776.md) |
| Current liabilities | $m | [190](/filings/0001628280-23-037539.md) | [184](/filings/0001628280-25-008401.md) | [188](/filings/0001628280-26-032536.md) | [185](/filings/0001628280-26-032536.md) | [177](/filings/0001628280-26-032536.md) | [176](/filings/0001628280-26-032536.md) | [172](/filings/0001628280-26-033836.md) | [182](/filings/0001628280-26-053776.md) | [334](/filings/0001628280-26-032536.md) | [179](/filings/0001628280-26-053776.md) | [173](/filings/0001628280-26-033836.md) | [197](/filings/0001628280-26-053776.md) |
| Total liabilities | $m | [507](/filings/0001628280-23-037539.md) | [485](/filings/0001628280-25-008401.md) | [486](/filings/0001628280-26-032536.md) | [477](/filings/0001628280-26-032536.md) | [466](/filings/0001628280-26-032536.md) | [446](/filings/0001628280-26-032536.md) | [436](/filings/0001628280-26-033836.md) | [433](/filings/0001628280-26-053776.md) | [601](/filings/0001628280-26-032536.md) | [525](/filings/0001628280-26-053776.md) | [516](/filings/0001628280-26-033836.md) | [534](/filings/0001628280-26-053776.md) |
| Long-term debt | $m | [266](/filings/0001628280-23-037539.md) | [258](/filings/0001628280-25-008401.md) | [255](/filings/0001628280-24-021349.md) | [252](/filings/0001628280-24-035846.md) | [247](/filings/0001628280-24-045949.md) | [231](/filings/0001628280-26-032536.md) | [231](/filings/0001628280-25-022383.md) | [219](/filings/0000030305-25-000008.md) | [216](/filings/0001628280-25-049803.md) | [300](/filings/0001628280-26-053776.md) | [299](/filings/0001628280-26-033836.md) | [273](/filings/0001628280-26-053776.md) |
| Current portion of debt | $m | [6.3](/filings/0001628280-23-037539.md) | [7.8](/filings/0001628280-25-008401.md) | [9.4](/filings/0001628280-24-021349.md) | [10.9](/filings/0001628280-24-035846.md) | [10.9](/filings/0001628280-24-045949.md) | [12.5](/filings/0001628280-26-032536.md) | [12.5](/filings/0001628280-25-022383.md) | [12.5](/filings/0000030305-25-000008.md) | [12.5](/filings/0001628280-25-049803.md) | [5.0](/filings/0001628280-26-053776.md) | [5.0](/filings/0001628280-26-033836.md) | [5.0](/filings/0001628280-26-053776.md) |
| Shareholders' equity | $m | [635](/filings/0001628280-24-045949.md) | [636](/filings/0001628280-26-032536.md) | [645](/filings/0001628280-26-032536.md) | [655](/filings/0001628280-26-032536.md) | [664](/filings/0001628280-26-032536.md) | [680](/filings/0001628280-26-053776.md) | [692](/filings/0001628280-26-053776.md) | [706](/filings/0001628280-26-053776.md) | [649](/filings/0001628280-26-032536.md) | [661](/filings/0001628280-26-053776.md) | [670](/filings/0001628280-26-053776.md) | [690](/filings/0001628280-26-053776.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.3 d](/filings/0001628280-24-045949.md) | [26.5 d](/filings/0001628280-26-032536.md) | [(1.6)](/filings/0001628280-26-032536.md) | [3.5 d](/filings/0001628280-26-032536.md) | [13.9 d](/filings/0001628280-26-032536.md) | [18.4 d](/filings/0001628280-26-032536.md) | [0.8](/filings/0001628280-26-033836.md) | [22.4 d](/filings/0001628280-26-053776.md) | [18.1 d](/filings/0001628280-26-032536.md) | [(74.7) d](/filings/0001628280-26-032536.md) | [11.2](/filings/0001628280-26-033836.md) | [33.5 d](/filings/0001628280-26-053776.md) |
| Capital expenditure | $m | [5.1 d](/filings/0001628280-24-045949.md) | [3.5 d](/filings/0001628280-26-032536.md) | [5.0](/filings/0001628280-26-032536.md) | [3.3 d](/filings/0001628280-26-032536.md) | [2.0 d](/filings/0001628280-26-032536.md) | [3.8 d](/filings/0001628280-26-032536.md) | [4.8](/filings/0001628280-26-033836.md) | [4.3 d](/filings/0001628280-26-053776.md) | [2.1 d](/filings/0001628280-26-032536.md) | [4.1 d](/filings/0001628280-26-032536.md) | [2.9](/filings/0001628280-26-033836.md) | [3.6 d](/filings/0001628280-26-053776.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.6](/filings/0001628280-24-035846.md) | [14.8](/filings/0001628280-24-045949.md) | [14.9](/filings/0001628280-26-032536.md) | [14.8](/filings/0001628280-26-032536.md) | [15.0](/filings/0001628280-26-032536.md) | [15.1](/filings/0001628280-26-032536.md) | [15.2](/filings/0001628280-26-033836.md) | [15.2](/filings/0001628280-26-053776.md) | [15.0](/filings/0001628280-26-032536.md) | [15.4](/filings/0001628280-26-032536.md) | [15.6](/filings/0001628280-26-033836.md) | [15.6](/filings/0001628280-26-053776.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,099,779 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053776.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.